Literature DB >> 191219

Excretion of galactitol in the urine of heterozygotes of both forms of galactosemia.

F C Sitzmann, R D Schmid, H Kaloud.   

Abstract

In 36 heterozygotes with Gal-1-PUT deficiency and 3 heterozygotes with galactokinase deficiency galactitol (and galactose) was determined in the urine 2 and 4 h after an intravenous injection of 350 mg galactose/kg body weight (maximum dosis in adults 16 g). For the sake of comparison 10 healthy children and 5 adults, also 4 homozygotes with Gal-1-PUT deficiency and one sick child with galactokinase deficiency were included in this study. The heterozygotes with Gal-1-PUT deficiency demonstrated the same galactitol excretion as the healthy probands, while heterozygotes with galactokinase deficiency excreted a four-fold higher quantity of galactitol than the healthy and heterozygous probands of Gal-1-PUT deficiency. The child with the galactokinase deficiency excreted galactitol for a period of more than 24 h. These results are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191219     DOI: 10.1016/0009-8981(77)90202-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Inexplicable infantile cataracts and partial maternal galactose disorder.

Authors:  M Brivet; V Abadie; T Soni; G Cheron; J L Dufier
Journal:  Arch Dis Child       Date:  1986-05       Impact factor: 3.791

Review 2.  Clinical features of galactokinase deficiency: a review of the literature.

Authors:  A M Bosch; H D Bakker; A H van Gennip; J V van Kempen; R J A Wanders; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

3.  Renal excretion of galactose and galactitol in patients with classical galactosaemia, obligate heterozygous parents and healthy subjects.

Authors:  P Schadewaldt; S Killius; L Kamalanathan; H W Hammen; K Strassburger; U Wendel
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

4.  Galactose intolerance and the risk of cataract.

Authors:  A F Winder; P Fells; R B Jones; R D Kissun; I S Menzies; J N Mount
Journal:  Br J Ophthalmol       Date:  1982-07       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.